Bharat Biotech Covid Vaccine
-
{
- All
- News
- Videos
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
Bharat Biotech Says Intranasal Covid Vaccine Found Safe In Booster Trials
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe.
-
Bharat Biotech Expects Regulator's Nod For Intranasal Covid Vaccine In Aug
Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said.
-
Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval
Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.
-
Bharat Biotech, WHO To Meet Over Covaxin Emergency Use Listing On June 23
In a major boost for Bharat Biotech, the World Health Organisation (WHO) has accepted its Expression of Interest (EoI) for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23.
-
Further Evaluation On Covaxin Shot Needed For Elderly, Children: Study
A COVID-19 vaccine developed by Bharat Biotech is safe and has shown high levels of antibody response in a mid-stage trial, but follow-on studies are needed to evaluate the shot for children and older people, a peer-reviewed study showed.
-
Day After Serum Institute, Bharat Biotech Rolls Out Homegrown Vaccine
The first batches of Covaxin, the Bharat Biotech's coronavirus vaccine, left Hyderabad early this morning for Delhi and 10 other cities, a day after Serum Institute of India rolled out its vaccine against COVID-19 ahead of the nationwide inoculation drive which officials say will be the 'world's biggest'.
-
Bharat Biotech's COVID-19 Vaccine 'Covaxin' Commences Phase-3 Trial At AIIMS: Report
Phase-three of human clinical trial of the India-made COVID-19 vaccine candidate Covaxin began at AIIMS in Delhi on Thursday with Dr MV Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
Bharat Biotech Says Intranasal Covid Vaccine Found Safe In Booster Trials
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe.
-
Bharat Biotech Expects Regulator's Nod For Intranasal Covid Vaccine In Aug
Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said.
-
Covaxin Maker Bharat Biotech's Nasal Booster Dose Trials Get Approval
Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.
-
Bharat Biotech, WHO To Meet Over Covaxin Emergency Use Listing On June 23
In a major boost for Bharat Biotech, the World Health Organisation (WHO) has accepted its Expression of Interest (EoI) for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23.
-
Further Evaluation On Covaxin Shot Needed For Elderly, Children: Study
A COVID-19 vaccine developed by Bharat Biotech is safe and has shown high levels of antibody response in a mid-stage trial, but follow-on studies are needed to evaluate the shot for children and older people, a peer-reviewed study showed.
-
Day After Serum Institute, Bharat Biotech Rolls Out Homegrown Vaccine
The first batches of Covaxin, the Bharat Biotech's coronavirus vaccine, left Hyderabad early this morning for Delhi and 10 other cities, a day after Serum Institute of India rolled out its vaccine against COVID-19 ahead of the nationwide inoculation drive which officials say will be the 'world's biggest'.
-
Bharat Biotech's COVID-19 Vaccine 'Covaxin' Commences Phase-3 Trial At AIIMS: Report
Phase-three of human clinical trial of the India-made COVID-19 vaccine candidate Covaxin began at AIIMS in Delhi on Thursday with Dr MV Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
